Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. with three other
companies in this sector in China:
Zhejiang Ausun Pharmaceutical Co Ltd
sales of 240.19 million Chinese Renmimbi [US$35.04 million]
of which 100%
was API and Intermediates),
Hainan Shuangcheng Pharmaceuticals Co Ltd
(246.77 million Chinese Renmimbi [US$36.00 million]
of which 88%
was Self-made medicine Business), and
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
(269.59 million Chinese Renmimbi [US$39.33 million]
of which 98%
was Chinese Herbal Medicine Trade).
Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. reported sales of 176.21 million Chinese Renmimbi (US$25.71 million)
December of 2017.
increase of 42.5%
versus 2016, when the company's sales were 123.62 million Chinese Renmimbi.
Sales of Medicine saw an increase
50.2% in 2017, from
96.20 million Chinese Renmimbi to 144.53 million Chinese Renmimbi.